Ross Breckenridge, Director at REVA Medical, Inc. (RVA), bought 1,000 shares at $4.09 ($4K) on 2015-06-04, disclosed to the SEC on 2015-06-05.
Open-market purchase of $4k RVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.